Hygeia Medical Group was established in 2004 and registered overseas. It is a listed company on the main board of Hong Kong with the stock code of 06078.HK (China's top 500 listed companies). As a medical group with oncology business as its core, it is committed to making medical care warmer and life healthier, and meeting the unmet needs of cancer patients in China and neighboring countries.

Since the start of its business, the Group has established a network of hospitals and tumor treatment centers with oncology business as the core, covering many provinces and cities in China through organic growth, strategic acquisitions and cooperation with hospital partners. As of now, the Group has more than 20 hospital projects in operation and under construction, as well as several tumor centers, with a total of more than 15,000 employees, more than 20,000 open beds, and business scope covering 18 provinces in China.

The group has a wholly-owned subsidiary, Shanghai Gammastar Technology Development Co., Ltd., which is a high-tech enterprise in China. It independently develops and produces gyroscopic cobalt 60 stereotactic radiotherapy system (gyro knife), which has won the second prize of the National Science and Technology Progress Award. It can be used for the treatment of head and body tumors. With advanced stereotactic radiotherapy equipment, it provides more effective comprehensive treatment services for tumor patients.